Mink Historical Income Statement

INKT Stock  USD 0.72  0.03  4.35%   
Historical analysis of Mink Therapeutics income statement accounts such as Interest Expense of 216.6 K or Selling General Administrative of 5.5 M can show how well Mink Therapeutics performed in making a profits. Evaluating Mink Therapeutics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Mink Therapeutics's future profits or losses.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Mink Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Mink Therapeutics is a good buy for the upcoming year.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Mink Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
For more information on how to buy Mink Stock please use our How to Invest in Mink Therapeutics guide.

About Mink Income Statement Analysis

Mink Therapeutics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Mink Therapeutics shareholders. The income statement also shows Mink investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Mink Therapeutics Income Statement Chart

At this time, Mink Therapeutics' Net Interest Income is comparatively stable compared to the past year. Other Operating Expenses is likely to gain to about 23.5 M in 2024, whereas Selling General Administrative is likely to drop slightly above 5.5 M in 2024.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Mink Therapeutics. It is also known as Mink Therapeutics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.
Most accounts from Mink Therapeutics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Mink Therapeutics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Mink Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
For more information on how to buy Mink Stock please use our How to Invest in Mink Therapeutics guide.At this time, Mink Therapeutics' Net Interest Income is comparatively stable compared to the past year. Other Operating Expenses is likely to gain to about 23.5 M in 2024, whereas Selling General Administrative is likely to drop slightly above 5.5 M in 2024.
 2021 2022 2023 2024 (projected)
Interest Expense2.4M253.3K228.0K216.6K
Depreciation And Amortization78.0K121.7K204.6K118.7K

Mink Therapeutics income statement Correlations

0.84-0.990.850.44-0.080.57-0.42-0.35-0.410.3-0.40.570.78-0.130.84-0.08-0.060.10.77-0.74-0.74
0.84-0.810.840.24-0.090.35-0.34-0.34-0.320.03-0.30.350.92-0.110.650.05-0.170.10.88-0.6-0.6
-0.99-0.81-0.84-0.470.04-0.670.440.360.44-0.430.43-0.67-0.70.15-0.830.2-0.04-0.07-0.690.670.67
0.850.84-0.840.61-0.490.68-0.78-0.7-0.760.37-0.760.680.81-0.550.84-0.21-0.380.510.58-0.44-0.44
0.440.24-0.470.61-0.680.55-0.64-0.36-0.640.4-0.640.550.37-0.390.84-0.02-0.410.71-0.10.10.1
-0.08-0.090.04-0.49-0.68-0.20.790.680.76-0.010.76-0.2-0.350.73-0.48-0.090.89-1.00.15-0.14-0.14
0.570.35-0.670.680.55-0.2-0.7-0.6-0.740.93-0.741.00.15-0.590.55-0.790.160.230.04-0.05-0.05
-0.42-0.340.44-0.78-0.640.79-0.70.951.0-0.511.0-0.7-0.380.93-0.590.440.57-0.8-0.050.080.08
-0.35-0.340.36-0.7-0.360.68-0.60.950.94-0.420.94-0.6-0.340.96-0.380.490.54-0.67-0.140.180.18
-0.41-0.320.44-0.76-0.640.76-0.741.00.94-0.571.0-0.74-0.340.94-0.570.50.51-0.76-0.020.050.05
0.30.03-0.430.370.4-0.010.93-0.51-0.42-0.57-0.570.93-0.21-0.480.28-0.890.40.04-0.240.150.15
-0.4-0.30.43-0.76-0.640.76-0.741.00.941.0-0.57-0.74-0.330.94-0.560.50.51-0.770.00.040.04
0.570.35-0.670.680.55-0.21.0-0.7-0.6-0.740.93-0.740.15-0.590.55-0.790.160.230.04-0.05-0.05
0.780.92-0.70.810.37-0.350.15-0.38-0.34-0.34-0.21-0.330.15-0.120.740.35-0.490.360.83-0.62-0.62
-0.13-0.110.15-0.55-0.390.73-0.590.930.960.94-0.480.94-0.59-0.12-0.250.560.52-0.720.14-0.09-0.09
0.840.65-0.830.840.84-0.480.55-0.59-0.38-0.570.28-0.560.550.74-0.250.08-0.360.510.44-0.43-0.43
-0.080.050.2-0.21-0.02-0.09-0.790.440.490.5-0.890.5-0.790.350.560.08-0.420.090.24-0.19-0.19
-0.06-0.17-0.04-0.38-0.410.890.160.570.540.510.40.510.16-0.490.52-0.36-0.42-0.88-0.10.10.1
0.10.1-0.070.510.71-1.00.23-0.8-0.67-0.760.04-0.770.230.36-0.720.510.09-0.88-0.150.140.14
0.770.88-0.690.58-0.10.150.04-0.05-0.14-0.02-0.240.00.040.830.140.440.24-0.1-0.15-0.85-0.85
-0.74-0.60.67-0.440.1-0.14-0.050.080.180.050.150.04-0.05-0.62-0.09-0.43-0.190.10.14-0.851.0
-0.74-0.60.67-0.440.1-0.14-0.050.080.180.050.150.04-0.05-0.62-0.09-0.43-0.190.10.14-0.851.0
Click cells to compare fundamentals

Mink Therapeutics Account Relationship Matchups

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Mink Stock Analysis

When running Mink Therapeutics' price analysis, check to measure Mink Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mink Therapeutics is operating at the current time. Most of Mink Therapeutics' value examination focuses on studying past and present price action to predict the probability of Mink Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mink Therapeutics' price. Additionally, you may evaluate how the addition of Mink Therapeutics to your portfolios can decrease your overall portfolio volatility.